Local Casa Grande community oncology practice announces its new clinic location and additional cancer care services including PET/CT.

CASA GRANDE, Ariz., December 11, 2023 –  Cancer & Blood Specialists of Arizona, a partner practice of American Oncology Network (AON) (Nasdaq: AONC), announced today the relocation of its main clinic to 1281 East Cottonwood Lane in Casa Grande.

The new site is over 14,000 square feet and accommodates 10 private exam rooms and 20 infusion chairs. Additionally, the clinic is equipped with enhanced services such as diagnostic PET/CT imaging and state-of-the-art TruBeam radiation treatments.

“We are very excited about our new clinic and the services we can now offer our patients,” said Carlos E. Arce-Lara, MD, medical oncologist and hematologist at CBSA. “As a community oncologist, it is very important to have the space as well as tools to treat our patients with the newest treatments and diagnostic equipment as close to home as possible. Patients in Casa Grande will value this new treatment site greatly.”

“To better serve our patients, it is important that our clinics are able to deliver total comprehensive care in a space outfitted with the latest treatment options and equipment,” said Stephen “Fred” Divers, MD, chief medical officer at AON. “The new clinic provides ample space for our providers to deliver the same high-quality patient care they are known for while offering patients additional services in the form of PET/CT scans and radiation treatments. Congratulations to the clinic for securing this expansion and new services.”

Cancer & Blood Specialists of Arizona joined AON in early 2021. As part of the partnership, the clinic and providers have access to AON’s wide variety of services and support that allow them to practice with a patient-first mindset. Such services include access to AON’s in-house pathology and laboratory, specialty pharmacy for oral oncolytic medications and integrated patient care management.

“I am very proud to serve this community and be able to advance the field of oncology,” said Dr. Arce-Lara. “Thank you to American Oncology Network for this important investment and for being a partner in the growth of Casa Grande and Pinal County as a whole.”

For more information about AON, visit www.aoncology.com. For more information about CBSA, visit www.cancerbloodspecialistsaz.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 220 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.

About Cancer & Blood Specialists of Arizona
We are experienced physicians, nurse practitioners, nurses and clinical support staff who work collaboratively with our administrative support care team to provide compassionate, patient-centered care. With over 40 years of collective experience in the Casa Grande and Flagstaff areas, our physicians have a history of delivering the highest quality oncologic and hematologic care treatment that is based on cutting-edge research and experience. We work together as a team providing care with empathy, respect, and consideration of what is best for the whole person throughout your cancer fight. As each cancer journey is unique, we deliver the most advanced and innovative treatments tailored to every patient for the best possible outcome and experience. Learn more at www.cancerbloodspecialistsaz.com.  

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

Dr. Shah is a Board-certified medical oncologist and hematologist and sees patients at the Columbus clinic.

COLUMBUS, Ohio, November 6, 2023 –  Zangmeister Cancer Center and American Oncology Network (AON) (NASDAQ: AONC) are pleased to welcome Hiral A. Shah, MD, to the clinic. Dr. Shah is now accepting patients at the Columbus clinic.

Dr. Shah is a Board-certified physician specializing in medical oncology and hematology. She received her medical degree from Northeastern Ohio College of Medicine in Rootstown, Ohio, and has over 10 years of experience treating various cancer types. “It is an honor to be joining the physicians at Zangmeister Cancer Center,” said Shah. “Zangmeister has been a trusted cancer clinic in the community since its founding in 2007. The physicians carry high credibility, and I am excited to join them and their mission to advance cancer services and treatments as well as provide compassionate patient care.”

Zangmeister Cancer Center is equipped to deliver state-of-the-art and comprehensive cancer treatment in a compassionate and comforting environment. There are three locations including the main clinic in Columbus, a second clinic in Grove City and a third clinic in Westerville.

“Dr. Shah is an exceptional physician and will be an asset to our clinic,” said Jeanna L. Knoble, MD, medical oncologist and hematologist at Zangmeister Cancer Center. “We are continuously looking for opportunities to improve our patient care and services, and one way we can keep this promise is by inviting experienced physicians to join us in our efforts to elevate patient care and effectively serve our cancer patients.”

As a partner practice of AON, one of the fastest-growing networks of community oncology practices in the United States, the practice has access to a variety of services and resources that support the clinic’s patient care initiatives.

“Zangmeister Cancer Center was one of the first practices to join the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “We have witnessed the positive impact the physicians and staff have made in the communities they serve. Dr. Shah is an excellent addition to the care team. Congratulations to the practice on its expansion of the physician team.”

For more information about AON, visit www.aoncology.com. For more information about Zangmeister Cancer Center, visit www.zangcenter.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents more than 220 providers practicing across 20 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

About Zangmeister Cancer Center
Designed for easy access and patient comfort, the center offers all of the services patients need as part of their cancer care, including diagnostic imaging and chemotherapy treatment, laboratory services, genetic consultation, a specialty pharmacy, social support services and access to cancer clinical trials. Our highly skilled and compassionate physicians use the latest advancements in the diagnosis, treatment and prevention of cancer and blood disorders. Learn more at www.zangcenter.com.  

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network, LLC
Caroline.Hewitt@AONcology.com

Members of AON’s leadership team will speak and moderate several panel sessions at the Summit.

FORT MYERS, Fla., October 18, 2023 – American Oncology Network (AON) (Nasdaq: AONC) is pleased to announce that Stephen “Fred” Divers, MD, chief medical officer; James Gilmore, PharmD, chief pharmacy and clinical services officer; and Alti Rahman, MHA, MBA, CSSBB, chief strategy and innovation officer; and Susan Sabo-Wagner, MSN, RN, OCN, vice president of clinical innovation, have been invited to speak at the Association for Value-Based Cancer Care (AVBCC) 2023 Summit. The in-person event is scheduled for October 18 through October 20 in New York.

Divers, Gilmore, Rahman and Sabo-Wagner, who are members of AON’s leadership team, serve as Summit faculty and will be speaking and moderating specific sessions:

• Divers will participate on the panel for the following session: “Clinician Leadership Role in Transforming Cancer Care.”
• Gilmore will participate on the panel for the following session: “Value-Based Agreements in Oncology: What Cancer Care Practices are Doing in the Marketplace Today.”
• Rahman will participate on the panel for the following sessions: “Challenges in Transitioning to Value-Based Care,” “Transforming the Oncology Practice Clinically and Financially,” “The Essential to Achieving Success in Value-Based Care: Medically Integrated Pharmacies & Dispensaries,” and “How Do I Handle Bundle Payments.” Rahman will also moderate the following panel sessions: “Beyond EOM: How does Health Equity Fit in Multi-Stakeholder Value-Based Care Partnership” and “Artificial Intelligence and the Impact on Care Delivery Outcomes.” 
• Sabo-Wagner will participate on the panel for the following session: “Beyond EOM: How does Health Equity Fit in Multi-Stakeholder Value-Based Care Partnership.”

“Cancer is constantly evolving, and it requires us, as healthcare leaders and patient advocates, to follow suit and continuously elevate our learning so that we can improve patient outcomes,” said Divers, who also serves as a board member of Community Oncology Alliance. “The cancer fight is everyone’s responsibility and so much can be learned by looking to our partners throughout the industry and taking note of best practices. I am excited and honored to be a part of the panel discussion and to see my fellow AON leaders speaking in sessions so that we can explore best cancer practices in today’s environment together.”

“Value-based care is a main force that can close the cancer care gap and create healthcare equity,” said Rahman, who also serves as co-chair of AVBCC and a board member of Community Oncology Alliance. “I am passionate about these topics and sharing my knowledge in hopes to educate and inspire others to learn more about value-based care and more importantly, look for ways to increase access to care so that everyone can receive the right care at the right time.”

According to the AVBCC website, the Summit brings together over 300 experts across the oncology landscape including practitioners, pharmacists, payers, policymakers and other key stakeholders. Filled with various educational sessions, attendees will gain insightful and relevant information that can be implemented in clinics and institutions.

“We are honored to have representatives from AON speaking at this prestigious event,” said Todd Schonherz, AON’s chief executive officer. “To us as an organization, it is important that we consistently work toward being at the forefront of cancer care. We do this by sharing our expertise in the field with others so that cancer care is elevated and progresses alongside the advancements in medicine and technology.”

In addition to speaking at the Summit, Rahman and Sabo-Wagner have been invited to speak at the Community Oncology Alliance (COA) Payer Exchange Summit on Oncology Payment Reform event in late October and the Patient-Centered Oncology Care® conference in early November.

For more information about AON, visit www.aoncology.com. To learn more about the AVBCC’s Summit, visit www.valuebasedcancer.com/avbcc/2023-summit.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 96 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

The conference brings together healthcare and community oncology leaders for clinical education programs
and industry updates.

FORT MYERS, Fla., October 11, 2023 – American Oncology Network (AON) (Nasdaq: AONC) is pleased to announce its annual Clinical Summit conference, which is scheduled for October 12 through October 15 at the Bellagio Hotel in Las Vegas.

The conference brings together the network’s healthcare and oncology leaders and physicians from across the nation for a multi-day event. Attendees will discuss and learn about the latest advancements in oncology that will elevate patient care, all under the central theme of ‘Collaborate, Innovate and Celebrate.’

In addition to educational sessions and informative AON and industry update breakouts, this year’s conference features guest speaker Diely Pichardo, MD, a retired hematologist-oncologist, who will deliver the interactive session on well-being and career longevity. Attendees will also earn continuing medical education credits with Dr. Neil Love’s Research to Practice CME program and have access to a clinical trial and research session provided by AON clinical research leadership.

“The Clinical Summit is an exciting event that provides a platform for learning about the latest trends, sharing knowledge and building connections with others in community oncology so that cancer care can be improved,” said Todd Schonherz, AON’s chief executive officer. “The conference fosters innovation and collaboration within our community oncology industry, and we look forward to welcoming our physicians and leaders to this year’s event.”

AON is one of the nation’s fastest-growing networks focused on ensuring the viability of community oncology. Since its inception in 2018, the company has expanded to include over 200 healthcare providers in more than 75 clinics and has a current presence in 19 states.

“This year’s theme captures the AON journey perfectly,” said Stephen “Fred” Divers, MD AON’s chief medical officer and medical oncologist at Genesis Cancer and Blood Institute, one of AON’s first partner practices to join the organization. “AON celebrated its fifth anniversary in September, and as we look back on the past five years, we reflect on the tremendous impact that collaboration and innovation have had on AON’s success. The theme ‘Collaborate, Innovate and Celebrate’ is an ode to AON and the teams who have dedicated themselves to bringing AON to where it is today.”

For more information about AON, visit www.aoncology.com.

###

About American Oncology Network
American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 96 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients.

The organization provides unique and comprehensive protocols for managing administrative procedures and enhancing ancillary services for its affiliates. AON is able to aggregate volume and attain economies of scale, as it guides its member physicians and practices through the transition to value-based reimbursement models that improve the patient experience and help to reduce the per-capita cost of cancer care.

AON also provides a unique model of physician-led, community-based oncology management. With services such as a centralized specialty pharmacy, diagnostics, pathology, fully integrated electronic medical records, a care management team and a variety of financial assistance programs, an alliance with AON ensures that patients’ experiences are at the very pinnacle of cancer care today. Learn more at aoncology.com.

Contact for more information:
Caroline Hewitt, Vice President of Marketing
American Oncology Network
Caroline.Hewitt@AONcology.com

AON to Ring Nasdaq’s Closing Bell on September 21, 2023, to Commemorate First Day of Trading

FORT MYERS, Fla. and LOS ANGELES, September 20, 2023 – American Oncology Network, LLC (“AON” or the “Company”), a rapidly growing network of community-based oncology practices, and Digital Transformation Opportunities Corp. (Nasdaq: DTOC) (“DTOC”), a special purpose acquisition company focused on the healthcare industry, announced today the completion of their previously announced business combination (the “Business Combination”).

The combined company has been renamed American Oncology Network, Inc., and its common stock is expected to commence trading on the Nasdaq Stock Market LLC (“Nasdaq”) under the new ticker symbol “AONC” on September 21, 2023. The Business Combination was approved at a special meeting of DTOC’s stockholders on September 19, 2023.

In just five years since its inception in 2018, AON has grown to include over 1,500 employees and over 200 providers in more than 75 clinics serving over 450,000 patients nationwide. AON practices have access to fully integrated ancillary services such as a specialty pharmacy, lab and pathology, radiation therapy, and imaging. These services promote clinical coordination and seamless communication throughout all stages of the care process. AON practices deliver high-quality patient care by sharing resources and expertise across the network, providing access to leading clinical trials, staying at the forefront of clinical innovation, and advocating for their patients and the profession of community oncology.

The DTOC partnership and recent strategic investment from AEA Growth, a leading global investment firm, will help further AON’s goals of supporting community oncology practices and improving the patient experience by unlocking further growth through continuing to add new providers to the AON network, scaling ancillary services, introducing new service offerings, and expanding AON’s existing services to address the broader oncology market.

“Today is an important milestone for AON and celebrates our team’s hard work and dedication, which have been the keys to our growth and success,” said Todd Schonherz, Chief Executive Officer of AON. “AON is committed more than ever to expanding our reach and advancing cancer care in communities across the nation where too often patients experience accessibility barriers.”

“We are proud of our successful partnership with AON and look forward to seeing the company’s profound impact enable advanced treatment options, clinical research, and comprehensive care options nationwide,” said Kevin Nazemi, Chief Executive Officer of DTOC.

The combined company will continue to be led by AON’s Chief Executive Officer, Todd Schonherz; Chief Financial Officer, David Gould; and Chief Medical Officer, Dr. Stephen “Fred” Divers.

Paul Hastings LLP served as legal advisor to DTOC. Woolery & Co. PLLC and Dentons US LLP served as legal advisors to AON.

###

About American Oncology Network
The American Oncology Network (AON) (Nasdaq: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success of community oncology and other specialties. Launched in 2018, the rapidly expanding AON network represents 109 physicians and 86 nurse practitioners and physician assistants practicing across 19 states. The executive management team of AON encompasses more than four decades of oncology practice management experience, enabling physicians to focus on what matters most — providing the highest quality care for patients. Learn more at www.aoncology.com.

About DTOC
Digital Transformation Opportunities Corp. is a blank check company, led by Kevin Nazemi, Co-Founder and former Co-CEO of Oscar Health, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. DTOC’s Board of Directors includes Kevin Nazemi, Brad Fluegel (former Chief Strategy Officer of Walgreens and Anthem), Jim Moffatt (former Vice Chairman and Global CEO of Deloitte Consulting), and Heather Zynczak (former Chief Marketing Officer of Pluralsight and Domo). DTOC is focused on businesses operating in the healthcare industry. To learn more about Digital Transformation Opportunities Corp., visit www.dtocorp.com.

About AEA Growth
AEA Growth provides technology-enabled, healthcare and software companies with flexible capital and operational resources to accelerate growth. AEA Growth targets investments in category-leading, capital-efficient businesses with strong customer advocacy.

AEA Growth is part of AEA Investors LP. AEA Investors was founded in 1968 by the Rockefeller, Mellon and Harriman family interests and S.G. Warburg & Co. as a private investment vehicle for a select group of industrial family offices with substantial assets. AEA has an extraordinary global network built over many years which includes leading industrial families, business executives and leaders; many of whom invest with AEA as active individual investors and/or join its portfolio company boards or act in other advisory roles. Today, AEA’s approximately 120 investment professionals operate globally with offices in New York, Stamford, San Francisco, London, Munich and Shanghai. The firm manages funds that have approximately $19 billion of invested and committed capital including the leveraged buyouts of middle market companies and small business companies, growth capital and private investments.

For more information, please contact:

For AON:
David Gould, Chief Financial Officer
David.Gould@aoncology.com

For DTOC:
Kyle Francis, Chief Financial Officer
kyle@dtocorp.com

Forward-Looking Statements

Certain statements in this press release are forward-looking statements. Forward-looking statements generally relate to future events including future financial or operating performance of American Oncology Network, Inc. (“New AON”). Forward-looking statements generally relate to future events or New AON’s future financial or operating performance. For example, projections of future revenue and other metrics are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expect”, “intend”, “will”, “estimate”, “anticipate”, “believe”, “predict”, “potential” or “continue”, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements.

These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by New AON and its management, are inherently uncertain and are inherently subject to risks, variability and contingencies, many of which are beyond New AON’s control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (1) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain key relationships and retain its management and key employees; (2) costs related to the Business Combination; (3) changes in applicable laws or regulations; (4) the possibility that New AON may be adversely affected by other economic, business, and/or competitive factors; (5) New AON’s estimates of expenses and profitability; and (6) other risks and uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in New AON’s final prospectus relating to the Business Combination dated July 18, 2023 filed with the SEC, and in subsequent filings with the SEC. New AON cautions that the foregoing list of factors is not exclusive or exhaustive and investors should not place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. If any of these risks materialize or New AON’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that New AON does not presently know or that New AON currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect New AON’s expectations, plans or forecasts of future events and views as of the date of this communication. New AON anticipates that subsequent events and developments will cause New AON’s assessments to change. However, while New AON may elect to update these forward-looking statements at some point in the future, New AON specifically disclaims any obligation to do so, unless required by applicable law. These forward-looking statements should not be relied upon as representing New AON’s assessments as of any date subsequent to the date of this communication. New AON does not give any assurance that New AON will achieve its expectations. Accordingly, undue reliance should not be placed upon the forward-looking statements.